Mayo Clinic Labs @Work: Daniel Kronemann - Insights
As a clinical laboratory technologist, Daniel Kronemann enjoys going beyond his day-to-day work as he explores new ways to enhance processes and systems in Bacteriology.
Learn more about how direct ethanol biomarker testing at Mayo Clinic Laboratories provides heightened sensitivity and specificity to accurately assess alcohol use and alcohol use disorder.
New tests launched in August - Insights
In August 2022, Mayo Clinic Laboratories announced thirty-two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
PathWays Case Studies: Nov. 2018 - Insights
Mayo Clinic laboratory experts share three case studies in this month’s “PathWays” post and are challenging you to test your Clinical Pathology, Molecular Diagnostic, Hematopathology, and Dermatology pathology knowledge. Review the cases,...
CPT Codes and LOINC Updates Archives - Page 5 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
Week in Review: October 18 - Insights
Top highlights include: scientists continue to investigate mysterious vaping illnesses, a possible vaccine for breast cancer could be available in less than a decade, and determining if patients are sick from the flu or from vaping.
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 20 - Insights
This week’s Research Roundup highlights how fasting blood glucose levels provide an estimate of duration and progression of pancreatic cancer before diagnosis.
Pathways Case Studies: November 2019 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for November include the following sub-specialties: Cytogenetics, Genetics,...
Activity Metrics Dashboard - Insights
We are excited to share that the Activity Metrics Dashboard is now live on mayocliniclabs.com. We heard your feedback and created these reports to provide a more integrated, intuitive and customized experience on our website.
Learn how our melanoma testing identifies variants in 17 genes associated with diagnosis, prognosis, and treatment guidance.